Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Frontiers in Cardiovascular Medicine|June 5, 2024
Effectiveness of medication self-management, self-monitoring and a lifestyle intervention on hypertension in poorly controlled patients: The MEDICHY randomized trialFabián Unda Villafuerte, Joan Llobera Cànaves, Andreu Estela Mantolan, et al.Diagnostic Microbiology and Infectious Disease|August 6, 2016
Twenty-four cases of imported zika virus infections diagnosed by molecular methodsIzaskun Alejo-Cancho, Nuria Torner, Inés Oliveira, et al.Journal of Migration and Health|December 7, 2023
Multi-infection screening for migrant patients in UK primary care: Challenges and opportunitiesJessica Carter, Felicity Knights, Anna Deal, et al.BMJ Global Health|December 17, 2025
Healthcare access among migrants in Morocco: perspectives of migrant communities, primary healthcare professionals and civil society actorsOumnia Bouaddi, Stella Evangelidou, Moudrike Abdellatifi, et al.Microorganisms|May 25, 2024
Prevalence and Risk Factors for Colonization by Multidrug-Resistant Microorganisms among Long-Term Travelers and Recently Arrived MigrantsVíctor Monsálvez, Paula Bierge, María Luisa Machado, et al.Plos One|July 8, 2026
Assessing the content validity of the migrant health country profile tools in Tunisia: A mixed methods study protocolFarah Seedat, Stella Evangelidou, Abdedayem Khelifi, et al.International Journal of Cardiology|January 15, 2019
Perceived discrimination and stressful life events are associated with cardiovascular risk score in migrant and non-migrant populations: The RODAM studyFelix P Chilunga, Daniel Boateng, Peter Henneman, et al.Vaccine|May 4, 2025
Behavioural and social drivers of vaccination among child and adult migrants in Morocco: A qualitative interview studyOumnia Bouaddi, Mohamed Khalis, Moudrike Abdellatifi, et al.Journal of Global Health|November 2, 2019
Prevalence and determinants of type 2 diabetes among lean African migrants and non-migrants: the RODAM studyFelix P Chilunga, Peter Henneman, Karlijn Ac Meeks, et al.The Lancet. Infectious Diseases|September 28, 2019
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trialDora Buonfrate, Joaquin Salas-Coronas, José Muñoz, et al.Pageof 10